ISSN 1470-3947 (print)
ISSN 1479-6848 (online)

Searchable abstracts of presentations at key conferences in endocrinology

Published by BioScientifica
Endocrine Abstracts (2012) 29 P844 
|

Establishment of a Multidisciplinary Tumor Board for Patients with Neuroendocrine Neoplasms

A. Bianchi, D. Iacovazzo, F. Plastino, F. Lugli, A. Pontecorvi, G. Doglietto, A. Giordano, C. Barone, L. De Marinis & G. Rindi

Author affiliations

Introduction: Neuroendocrine neoplasms are rare and multiform requiring a multidisciplinary approach. We report the experience of a Neuroendocrine tumor board (TB) established at our University Hospital.

Aims: The aim is to share clinical and diagnostic data for best decision-making according to the existing ENETS guidelines.

Materials and methods: According to the indications for ENETS Centers of Excellence, meetings with experts in Endocrinology, Endoscopy, Nuclear Medicine, Oncology, Pathology, Radiology and Surgery are held; interactive computer-assisted presentation of 3 or 4 cases each time presented by one representative of the caring equipe; electronic reports written, circulated and stored; descriptive statistics for data analysis.

Results: TB started in December 2010, 21 biweekly meetings were completed, 50 cases discussed, 18 more than once; the diagnostic-therapeutic decision was tailored for each patient, in approximately 70% of cases according to the ENETS guidelines; the gallium PET/CT was identified as a special need and introduced as diagnostic standard in the second half of 2011; electronic reports constitute a shared database.

Conclusions: Our data indicate a good correlation between ENETS guidelines and clinical practice but underline the need for improvement for selected areas. The TB is a valid tool to develop suitable programs of care according to the best clinical evidence and guidelines.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

This Issue/Conference

Article tools

My recent searches